IRIDEX Corporation (IRIX) Financial Ratios
30 years of historical data (1995–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
30Y Low6.3·High45.6
P/FCF
N/A
—
5yr avg: 11.77
30Y Low4.2·High79.3
P/B Ratio
↑
8.07
↑+56% vs avg
5yr avg: 5.17
30Y Low0.6·High13.2
ROE
↓
-153.4%
↑-140% vs avg
5yr avg: -63.9%
30Y Low-153%·High34%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low0.0·High1.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IRIX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
IRIDEX Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $18M | $28M | $45M | $32M | $94M | $35M | $31M | $57M | $88M | $143M | $94M |
| Enterprise Value | $20M | $30M | $41M | $20M | $73M | $27M | $21M | $36M | $66M | $119M | $84M |
| P/E Ratio → | -1.91 | — | — | — | — | — | — | — | — | — | 185.80 |
| P/S Ratio | 0.36 | 0.57 | 0.87 | 0.56 | 1.75 | 0.96 | 0.70 | 1.35 | 2.12 | 3.10 | 2.25 |
| P/B Ratio | 8.07 | 13.17 | 4.76 | 1.86 | 4.04 | 2.00 | 1.35 | 1.91 | 2.88 | 3.65 | 2.79 |
| P/FCF | — | — | — | — | 11.77 | — | — | — | — | — | — |
| P/OCF | — | — | — | — | 11.47 | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
IRIX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.61 | 0.79 | 0.35 | 1.35 | 0.75 | 0.49 | 0.85 | 1.60 | 2.58 | 2.01 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | 103.82 |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | 288.98 |
| EV / FCF | — | — | — | — | 9.12 | — | — | — | — | — | — |
IRIX Profitability
Margins and return-on-capital ratios measuring operating efficiency
IRIDEX Corporation earns an operating margin of -17.1%. Operating margins have compressed from -13.2% to -17.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -153.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.1% | 40.1% | 42.0% | 44.5% | 42.4% | 42.8% | 41.3% | 41.0% | 37.3% | 45.1% | 47.8% |
| Operating Margin | -17.1% | -17.1% | -19.3% | -13.2% | -14.0% | -18.1% | -20.7% | -30.2% | -31.0% | -5.6% | 0.7% |
| Net Profit Margin | -18.3% | -18.3% | -18.5% | -13.2% | -9.7% | -17.4% | -20.3% | -30.1% | -30.9% | -25.4% | 1.1% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -153.4% | -153.4% | -71.5% | -37.2% | -25.7% | -31.6% | -33.5% | -42.4% | -36.9% | -32.2% | 1.4% |
| ROA | -28.0% | -28.0% | -24.9% | -16.6% | -13.6% | -20.2% | -23.0% | -30.8% | -28.7% | -26.0% | 1.1% |
| ROIC | -129.9% | -129.9% | -145.6% | -157.5% | -93.9% | -42.6% | -61.1% | -109.8% | -79.8% | -9.8% | 1.0% |
| ROCE | -48.8% | -48.8% | -39.0% | -22.9% | -27.2% | -29.7% | -32.3% | -41.6% | -36.3% | -6.9% | 0.8% |
IRIX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $2M ($5M total debt minus $2M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.21 | 2.21 | 0.29 | 0.10 | 0.11 | 0.24 | 0.14 | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 1.08 | -0.45 | -0.71 | -0.91 | -0.43 | -0.42 | -0.71 | -0.71 | -0.61 | -0.30 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | -12.34 |
| Debt / FCF | — | — | — | — | -2.65 | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
IRIX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.42x means IRIDEX Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.77x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 2.87x to 1.42x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | 1.42 | 2.12 | 2.87 | 3.34 | 2.92 | 3.12 | 3.57 | 3.80 | 5.42 | 4.14 |
| Quick Ratio | 0.77 | 0.77 | 1.35 | 2.02 | 2.74 | 2.26 | 2.29 | 2.78 | 2.89 | 4.04 | 2.65 |
| Cash Ratio | 0.14 | 0.14 | 0.54 | 1.12 | 1.89 | 1.34 | 1.29 | 1.91 | 2.09 | 2.81 | 1.35 |
| Asset Turnover | — | 1.67 | 1.51 | 1.35 | 1.11 | 1.30 | 1.25 | 1.02 | 1.00 | 0.96 | 1.00 |
| Inventory Turnover | 2.70 | 2.70 | 3.03 | 2.98 | 4.08 | 3.64 | 3.12 | 2.86 | 2.78 | 2.17 | 1.96 |
| Days Sales Outstanding | — | 62.95 | 67.93 | 62.58 | 65.79 | 73.20 | 78.32 | 77.82 | 69.00 | 79.27 | 81.13 |
IRIX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
IRIDEX Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | 0.5% |
| FCF Yield | — | — | — | — | 8.5% | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.7% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.7% |
| Shares Outstanding | — | $16M | $16M | $16M | $15M | $14M | $14M | $12M | $12M | $10M | $10M |
Peer Comparison
Compare IRIX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IRIXYou | $18M | -1.9 | — | — | 40.1% | -17.1% | -153.4% | -129.9% | — |
 LASE | $19M | -4.0 | — | — | 43.4% | -189.3% | -20.9% | -42.1% | — |
 ARAY | $45M | -24.5 | 11.7 | — | 32.1% | 1.7% | -2.5% | 3.0% | 12.6 |
 GKOS | $8B | -40.7 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 ATRC | $1B | -109.5 | 73.2 | 27.6 | 74.4% | -0.6% | -2.4% | -0.6% | 5.2 |
 ALGN | $12B | 29.9 | 14.0 | 24.6 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 ISRG | $160B | 57.2 | 43.3 | 64.2 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 SYK | $109B | 34.0 | 19.8 | 25.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 EW | $46B | 43.7 | 24.5 | 34.5 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 DXCM | $23B | 29.0 | 20.5 | 21.7 | 60.0% | 19.6% | 34.5% | 18.7% | 1.2 |
| Healthcare Median | — | 21.9 | 14.2 | 18.5 | 64.3% | -5.0% | -34.0% | -11.0% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See IRIX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRIX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRIX vs LASE
Side-by-side business, growth, and profitability comparison vs Laser Photonics Corporation.
Start ComparisonIRIX — Frequently Asked Questions
Quick answers to the most common questions about buying IRIX stock.
What is IRIDEX Corporation's P/E ratio?
IRIDEX Corporation's current P/E ratio is -1.9x. The historical average is 48.9x.
What is IRIDEX Corporation's ROE?
IRIDEX Corporation's return on equity (ROE) is -153.4%. The historical average is -15.2%.
Is IRIX stock overvalued?
Based on historical data, IRIDEX Corporation is trading at a P/E of -1.9x. Compare with industry peers and growth rates for a complete picture.
What are IRIDEX Corporation's profit margins?
IRIDEX Corporation has 40.1% gross margin and -17.1% operating margin.